You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 10, 2026
Sale
Calculated transaction value
$288.4K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 9, 2026
Public filing date
Nov 10, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$582.46
Nov 9, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 494 shares @ $583.8
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000185
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$943.52K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $491.15K |
| United Therapeutics Corp UTHR Current | Sale | Nov 9, 2026 | $288.4K |
| United Therapeutics Corp UTHR | Sale | Nov 9, 2026 | $163.98K |